384 related articles for article (PubMed ID: 21791023)
41. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease.
Borrelli M; Salvati VM; Maglio M; Zanzi D; Ferrara K; Santagata S; Ponticelli D; Aitoro R; Mazzarella G; Lania G; Gianfrani C; Auricchio R; Troncone R
Am J Gastroenterol; 2013 Nov; 108(11):1775-84. PubMed ID: 24060758
[TBL] [Abstract][Full Text] [Related]
42. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
43. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
[TBL] [Abstract][Full Text] [Related]
44. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
[TBL] [Abstract][Full Text] [Related]
45. [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].
Ling Y; Cao XS; Yu ZQ; Luo GH; Bai X; Su J; Dai L; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):184-8. PubMed ID: 17649712
[TBL] [Abstract][Full Text] [Related]
46. The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome.
Sarigul M; Yazisiz V; Bassorgun CI; Ulker M; Avci AB; Erbasan F; Gelen T; Gorczynski RM; Terzioglu E
Lupus; 2010 Feb; 19(2):138-45. PubMed ID: 19952070
[TBL] [Abstract][Full Text] [Related]
47. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
[TBL] [Abstract][Full Text] [Related]
48. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
49. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.
Li Z; Arijs I; De Hertogh G; Vermeire S; Noman M; Bullens D; Coorevits L; Sagaert X; Schuit F; Rutgeerts P; Ceuppens JL; Van Assche G
Inflamm Bowel Dis; 2010 Aug; 16(8):1299-310. PubMed ID: 20196149
[TBL] [Abstract][Full Text] [Related]
50. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
[TBL] [Abstract][Full Text] [Related]
51. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
[TBL] [Abstract][Full Text] [Related]
52. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
[TBL] [Abstract][Full Text] [Related]
53. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707
[TBL] [Abstract][Full Text] [Related]
54. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
[TBL] [Abstract][Full Text] [Related]
55. Effective expansion of forkhead box P3⁺ regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis.
Wu YE; Du ZR; Cai YM; Peng WG; Zheng GZ; Zheng GL; Wu LB; Li K
Mol Med Rep; 2015 Apr; 11(4):3134-42. PubMed ID: 25483347
[TBL] [Abstract][Full Text] [Related]
56. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
Claassen MA; de Knegt RJ; Tilanus HW; Janssen HL; Boonstra A
J Hepatol; 2010 Mar; 52(3):315-21. PubMed ID: 20129690
[TBL] [Abstract][Full Text] [Related]
57. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
58. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
[TBL] [Abstract][Full Text] [Related]
59. Aberrant frequency of IL-10-producing B cells and its association with the balance of Treg/Th17 in children with inflammatory bowel disease.
Zhu XM; Huang YM; Fan JF; Shi YZ
Pharmazie; 2015 Oct; 70(10):656-60. PubMed ID: 26601422
[TBL] [Abstract][Full Text] [Related]
60. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
Zhang Z; Zhao X; Lv C; Li C; Zhi F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
